Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04151667 · ClinicalTrials.gov registry record · Phase 2

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

A Phase 2 study of Multiple Myeloma, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
Phase 2
Development phase
33
Enrollment target
1
Study location

NCT04151667 is a Phase 2 study of Multiple Myeloma that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 33 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04151667, a Phase 2 study of Multiple Myeloma, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG Daratumumab Injection
  • DRUG Dexamethasone Oral
  • DRUG Lenalidomide Pill
  • DRUG Bortezomib Injection

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer & Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2019-11-22
Est. Completion 2026-05-07
Phase Phase 2

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04151667

The ClinicalTrials.gov registry entry for NCT04151667 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (94% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 4 interventions - of which Daratumumab Injection is the first listed.

NCT04151667 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04151667 about?

NCT04151667 is a clinical study titled "Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma". This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.

What is the current status of trial NCT04151667?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2019-11-22. Estimated completion is 2026-05-07.

What conditions does trial NCT04151667 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT04151667?

The interventions under investigation include: Daratumumab Injection (DRUG), Dexamethasone Oral (DRUG), Lenalidomide Pill (DRUG), Bortezomib Injection (DRUG).

Who is sponsoring clinical trial NCT04151667?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04151667 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.